chrisvoncsefalvay/vaers-outcomes huggingface dataset:
started experiencing a lot of joint pain, especially in my hands, elbows, and wrists/ shoulders/ hip/ knees; make something as simple as getting ready in the morning extremely painful; experiencing joint pain in my hands/ feet; This is a spontaneous report from a contactable Consumer or other non-health care professional (patient).  A 31-years-old female patient received first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on an unspecified date (at the age of 31-years-old) as dose 1, single for covid-19 immunization. Medical history included High blood pressure from an unknown date and unknown if ongoing. Patient had known allergies with milk. Concomitant medications were not reported. No covid prior vaccination and not tested post vaccination. It was reported that between her first and second COVID shot on 21Mar2021 04:00 PM, she started experiencing a lot of joint pain, especially in my hands, elbows, and wrists that make something as simple as getting ready in the morning extremely painful. AE resulted in doctor or other healthcare professional office/clinic visit. Treatment received for events reported with Predisone. Outcome of events was not recovered.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained. No further information is expected.
Sunday, April 18, 2021: at 4 PM, I received the COVID Shot 1 here. Stayed at pharmacy 15 min after shot, no pain, no redness, nothing. I felt good. Monday, April 19: at 4 AM, my arm starts to get sore and I cannot lift it. No redness. Tuesday, April 20: all day same issues: sore arm and I cannot lift it, no redness. Wednesday, April 21: early morning hours, the soreness is gone and I can lift my arm. All seems fine. No issues. Until?  Wednesday, April 28: 10 days after COVID Shot 1: area where the shot was started getting dark pink/red, with burning/itching feelings in arm, and pain in arm, also pain in left leg by my varicose veins shooting downward. Exhaustion sets in.  Thursday, April 29: leg pain is gone. Arm the same, area where the shot was starts getting dark pink/red, with burning/itching feelings in arm. Pain in arm is gone. My face cheeks are red and blotchy. Friday, April 30: Same as Thursday, minus the red face cheeks. Exhaustion is overwhelming. Saturday, May 1 at 1 AM the burning in my arm is so bad. I took a photo of my arm and notice the additional red/blotchy marks down my arm. Redness and burning is at the injection spot and the area below it. Finally went to see the pharmacist who injected me. He said take Benadryl for two days. Sunday, May 1 at 1 AM, burning sensation continues, the red blotches now become one large area of red blotch. Painful large area. Seems I am getting worse, not better.
threw up; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and VOMITING (threw up) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history).    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). On 30-Jan-2021, the patient experienced VOMITING (threw up). At the time of the report, PYREXIA (Fever), CHILLS (Chills) and VOMITING (threw up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test negative: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Vaccine was administered on 12/14/2015 and there has been intermittent blood and mucus in stool since 12/15/2015.
t105 w/DTP/OPV/HIB hospitalized overnoc for observation;
swelling, pain, and discoloration at the injection site up to three months after receiving the inital vaccination at the request of her nurse. she cannot sleep or lay down on her left arm. there is still a constant, sharp stinging pain at the injection site. she contacted the hospital that administered the shot and was informed by a nurse that the vaccination was given improperly (instead of being injected in the upper arm muscle, it was injected under her skin in her bicep area). We asked the hospital repeatedly to allow a doctor to see the injection site because of the pain she was going through and for months calls went unanswered, and they failed to report the improper administration of the vaccination even when we asked them to. This is why we are now reporting this ourselves. She was supposed to receive a second shingles vaccination but because of the improperly trained nursing staff and failure of responsibility at all level, she did decided it was best to forgo the second vaccination. The final thing the hospital did was prescribe a steriod tablet, after they asked her to take Alieve for two weeks to no avail. At this time, she is still experiencing severe pain at the injection site and the hospital has completely washed their hands of the situation.
Arm became unbearably sore - woke me up from sleep. Swelling at injection site. Felt fatigued until Monday the 12th in the afternoon.
inability to hear / very hard of hearing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 75-year-old female patient received BNT162b2 (BNT162B2), on 10Aug2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), for Covid-19 Immunization; Bnt162b2 (DOSE 2), for Covid-19 Immunization; Bnt162b2 (DOSE 3), for Covid-19 Immunization.  The following information was reported: HYPOACUSIS (non-serious), outcome "unknown", described as "inability to hear / very hard of hearing". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: It was reported that the patient had very hard of hearing, is calling to see when she can get the booster dose of the Pfizer BioNTech Covid vaccine. She has had four previous boosters of the Pfizer Covid vaccines, the last being administered on 10Aug2022. She developed a mild case of Covid on 09Sep2022, and tested positive 13Sep2022. Patient was struggling with inability to hear while on call, did not clarify if that developed or had worsened after vaccinations.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
8 days after vaccine developed diffuse hives. three weeks after vaccine developed angioedema of lips.
The patient was set to have received the second dose of the series on 1/25/21 and instead received it on 1/19/21. The patient reported injection site soreness for 24 hours following the administration of the vaccine.
My legs have felt like lead; Legs aching, hurting like they are recovering from serious muscle cramps; Legs aching, hurting like they are recovering from serious muscle cramps; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in 2021 as dose 3, (booster), single (Lot number: En630J) at the age of 61 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthmatics" (unspecified if ongoing); "Allergy" (unspecified if ongoing), notes: to many to name. The patient took concomitant medications. Vaccination history included: BNT162b2 (DOSE 2, SINGLE, Batch/Lot No: ER8730, Location of injection: Arm Right, Vaccine Administration Time: 01:00 PM), administration date: 26Mar2021, when the patient was 60-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 1, SINGLE, Batch/Lot No: FK9729, Location of injection: Arm Left, Vaccine Administration Time: 04:00 PM), administration date: 08Feb2022, when the patient was 60-year-old, for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 02Aug2021, 4 months 30 days after the suspect product(s) administration, outcome "not recovered", MUSCLE SPASMS (non-serious) with onset 02Aug2021, outcome "not recovered" and all described as "Legs aching, hurting like they are recovering from serious muscle cramps"; LIMB DISCOMFORT (non-serious) with onset 02Aug2021, 4 months 30 days after the suspect product(s) administration, outcome "not recovered", described as "My legs have felt like lead". The events "my legs have felt like lead" and "legs aching, hurting like they are recovering from serious muscle cramps" required physician office visit. Therapeutic measures were taken as a result of limb discomfort, pain in extremity, muscle spasms.  Additional information: The Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. patient went for consultation another Dr on Monday 25Apr2022 for the treatment of adverse event. seriousness criteria did not leads to death, life threatening, caused/prolonged hospitalization,  disabling/incapacitating and congenital anomaly/birth defect . Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.   Follow-up attempts are completed. No further information is expected.
3 days after receiving Anthrax vaccine patient/vaccinee complaints of pain on hands, elbows, shoulders, and hips, swollen and weakness (can't grip) both hands, trouble walking. He was brought to local hospital and was seen by local physician, diagnose with "Viral Syndrome" treated with Toradol 60mg IM and given Aleve OTC. Blood testing was performed pending result. He was given illness certificate slip for no work/duty for 2 days and follow up on 28 Jan 15. May return to duty 19 Jan 15.
having an allergic reaction to the first dose; severe dry mouth; flushing in face/ felt flushed on neck and both of her arms; felt a little foggy; face felt tingly; numbness sensation in entire face; Slight swelling on the back of her throat; very tired; This is spontaneous report from a non-contactable nurse (patient). A female patient of an unspecified age (Age: 51, Units: unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Vaccine received the 14Dec2020. She experienced, 10 minutes after her shot, 'severe dry mouth, flushing in face, was talking extra fast'. Thought she was fine. Waited the proper amount of observation time. 'felt a little foggy'. Drove home. While driving her 'face felt tingly, numbness sensation in entire face, felt flushed on neck and both of her arms. More noticeable on right side and more mild on left side. Slight swelling on the back of her throat. Was taken in for monitoring, vitals were normal. Became very tired. Was given diphenhydramine hydrochloride (BENADRYL), and within 20-30 mins was totally fine. Did not have trouble breathing'. Caller wanted to hear from us on whether or not she should get the second dose of the COVID vaccine after having an allergic reaction to the first dose. The patient underwent lab tests and procedures which included laboratory test: vitals were normal on 14Dec2020. The outcome of events was resolved on 14Dec2020. The events were reported as non-serious.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained. No further information is expected.
Vaccine administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion.; Vaccine administered to patient after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion.) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 9:32 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 9:32 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered to patient after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion.). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 19.91 years.  Concomitant products were not provided.  On 06-Apr-2021, The vaccine with batch number 044B21A was moved to fridge. On 15-Apr-2021, 18 vials were moved to the clinic. On 15-Apr-2021 at 9 AM, vials temperature excursion reported as 34 degrees fahrenheit. The condition of vaccine prior to vaccination was not frozen. The vaccine beyond use date was reported as 09-May-2021.   It was reported that, the storage condition at the time of the excursion was cooler storage during high-pace COVID-19 vaccination clinic. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a traceable temperature monitor at every hour.  The health care professional explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree fahrenheit.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
Very weak, continuous trembling and twitching, unable to walk well, headache, temperature 101 degrees.   Lasting for 24 hours.
Double vision. Dizzy. Unable to walk (- coordination decreased) without holding on. Headache.
Patient contracted COVID after being fully vaccinated Sore throat, shortness of breath, body aches, cough, fatigue
lymph nodes under arm of injection swollen and painful; muscle ache; pain in arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), LYMPHADENOPATHY (lymph nodes under arm of injection swollen and painful), HEADACHE (headache) and MYALGIA (muscle ache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included VALSARTAN, EZETIMIBE, ACETYLSALICYLIC ACID (BABY ASPIRIN), ROSUVASTATIN, DULOXETINE, VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) and RALOXIFENE HYDROCHLORIDE (EVISTA) for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in arm) and HEADACHE (headache). On 15-Mar-2021, the patient experienced LYMPHADENOPATHY (lymph nodes under arm of injection swollen and painful) and MYALGIA (muscle ache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg. At the time of the report, PAIN IN EXTREMITY (pain in arm), LYMPHADENOPATHY (lymph nodes under arm of injection swollen and painful) and MYALGIA (muscle ache) outcome was unknown and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant medication included l-lyfin.   Patient previously had a reaction to shingle shot in November.
This spontaneous case was reported by a pharmacist and describes the occurrence of DYSMENORRHOEA (It occurred within a week of getting the vaccine, vaginal bleeding and cramping) and VAGINAL HAEMORRHAGE (She got vaginal bleeding after both doses, It stopped on its own lasting no more than 3 days of heavy period then spotting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSMENORRHOEA (It occurred within a week of getting the vaccine, vaginal bleeding and cramping) and VAGINAL HAEMORRHAGE (She got vaginal bleeding after both doses, It stopped on its own lasting no more than 3 days of heavy period then spotting). At the time of the report, DYSMENORRHOEA (It occurred within a week of getting the vaccine, vaginal bleeding and cramping) outcome was unknown and VAGINAL HAEMORRHAGE (She got vaginal bleeding after both doses, It stopped on its own lasting no more than 3 days of heavy period then spotting) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not provided Treatment information was not reported It was reported that the symptoms included cramping and vaginal bleeding were more severe after the first dose than the second dose. The bleeding stopped on its own, lasting no more than 3 days
Numbness in right arm after 30 minutes, spread to face and head in the next couple hours, lastly tingling feet, seen in ER but dismissed quickly, the numbness was gone by the next morning
Body temperature 99.2, chills, achy joints and muscles, low grade headache, extreme fatigue, injection site soreness
@ 1130 pt had sz lasting 1 min;eyes rolled in head;pt shaking;post sz pt c/o vomiting, dizzy, weakness;
Temp of 100.9, body aches, upset stomach, cold chills, and headache
This spontaneous report as received from a pharmacist refers to a 50 year old female patient with psoriasis. The patient no drug allergies. On 24-OCT-2014, the patient was vaccinated with a dose of ZOSTAVAX (lot number K010647, expiry date 30-OCT-2015). There was no concomitant medications reproted. On 26-OCT-2014, the patient experienced redness, warmth, and swelling at the injection site after receiving ZOSTAVAX and described it as looks like a bulls eye. The patient was given massage, cool compress and TYLENOL. There was no lab tests performed. The outcome of redness, warmth, and swelling at the injection site was reported as not recovered/not resolved. The patient did not seek medical attention. This is one of the two reports received from the same reporter. Additional information has been requested.
I woke up at 7 AM and as I got out of bed I suffered a severy dizzy spell. Thought it was just a passing incident.  I saw a cardiologist on August 30th who prescribed Meclizine for 30 days with one tab 3 times a day. The dizziness continues and I have seen my family clininc PA who thinks my problem may be Positional Vertigo and has referred me to an ENT doctor; Awaiting appointment.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium
Really sick for a few weeks. Flu like symptoms which resulted in needing two rounds of antibiotics because I developed a sinus infection and bronchitis. Had to see my provider about a week after the vaccine.
2 weeks post booster shot I've started to experience persistent hives that itch intensely, cause a red rash, and worsen at night. I have never previously suffered from hives or skin sensitivity or any allergies. Oral antihistamines seem to be helping but the itching is very intense, especially on hands and soles of the feet.
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 83-year-old female patient who received SHINGRIX (batch number JC92P, expiry date 22nd November 2020) for prophylaxis. Concomitant products included FLUZONE. On 23rd August 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 6th September 2018, 14 days after receiving SHINGRIX, the patient experienced rash. On an unknown date, the outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX in the left deltoid. On 23rd August 2018, the patient received FLUZONE in the right deltoid (batch number: UI977AB, expiry date: 9th March 2019). The patient experienced rash on the back of her leg and ankle. The patient went to urgent care for treatment. The urgent care did not consider FLUZONE as suspect.
Headache, Myalgia, Fever, UrticariaPruritus, NauseaVomiting, Fatigue Narrative: Symptoms started day after injection, fever 101.7 , sever headache, fatigue, arm pain and numbness. Fever and aches continued next day, fatigue and nausea improved. Next day, has slight headache, no fever, still pain/redness at injection site.
burning arm; sore arm/ache in entire left arm to shoulder blade and neck; sore arm/ache in entire left arm to shoulder blade and neck; sore arm/ache in entire left arm to shoulder blade and neck; numbness in fingertips; pinched nerve in neck; inflammation; This is a spontaneous report from a contactable consumer or other non hcp (patient).    A 47-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6206, Expiration date: unknown) as single dose administered in left arm on 12Mar2021 15:30 for COVID-19 immunization.  Medical history included Hashimoto's thyroiditis, extremely low iron saturation, anemia, and Allergy to Sulfa. Concomitant medication included SYNTHROID, MOTRIN. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced burning in arm, sore arm/ache in entire left arm to shoulder blade and neck on 12Mar2021 at 16:00, and numbness in fingertips, a pinched nerve in neck, and inflammation on an unspecified date in Mar2021. It was reported that within minutes of vaccine the patient had considerable burning in arm. Nurse said that was normal. No other symptoms moving forward except for sore arm. A few days later entire arm continued to burn and numbness in fingertips. It had been almost 3 weeks, burning and ache in entire left arm to shoulder blade and neck in addition to numbness in fingertips. She believed they hit a nerve. She went to a physical therapist who was treating it as a pinched nerve in neck due to inflammation.  Therapeutic measures were taken as a result of events. The outcome of the events was resolving.
CLIENT CONTRACTED COVID DESPITE FULLY VACCINATED AS OF 1/24/21.  LAB POSITIVE PCR.
Lymph node swelling in left arm - arm of injection. Fever 100 - 102. Headache. Stiffness in neck. Joint Pain.